<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cardiovasc. Med.</journal-id><journal-title-group>
<journal-title>Frontiers in Cardiovascular Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cardiovasc. Med.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2297-055X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcvm.2025.1740710</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Non-invasive pressure-volume analysis: a novel method for evaluating ventricular function in patients with aortic stenosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Ribic</surname><given-names>Darijan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/3270361/overview"/><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role></contrib>
<contrib contrib-type="author"><name><surname>Remme</surname><given-names>Espen W.</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/1689442/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role></contrib>
<contrib contrib-type="author"><name><surname>Smiseth</surname><given-names>Otto A.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Massey</surname><given-names>Richard J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Eek</surname><given-names>Christian H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib>
<contrib contrib-type="author"><name><surname>Kvitting</surname><given-names>John-Peder Escobar</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:href="https://loop.frontiersin.org/people/601124/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Gullestad</surname><given-names>Lars</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role></contrib>
<contrib contrib-type="author"><name><surname>Broch</surname><given-names>Kaspar</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role></contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Russell</surname><given-names>Kristoffer</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref><uri xlink:href="https://loop.frontiersin.org/people/3267755/overview" /><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Department of Cardiology, Oslo University Hospital</institution>, <city>Oslo</city>, <country country="no">Norway</country></aff>
<aff id="aff2"><label>2</label><institution>Institute for Clinical Medicine, University of Oslo</institution>, <city>Oslo</city>, <country country="no">Norway</country></aff>
<aff id="aff3"><label>3</label><institution>Institute of Surgical Research, Oslo University Hospital</institution>, <city>Oslo</city>, <country country="no">Norway</country></aff>
<aff id="aff4"><label>4</label><institution>The Intervention Centre, Oslo University Hospital</institution>, <city>Oslo</city>, <country country="no">Norway</country></aff>
<aff id="aff5"><label>5</label><institution>Department of Cardiothoracic Surgery, Oslo University Hospital</institution>, <city>Oslo</city>, <country country="no">Norway</country></aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label><bold>Correspondence:</bold> Kristoffer Russell <email xlink:href="mailto:krruss@ous-hf.no">krruss@ous-hf.no</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-22"><day>22</day><month>01</month><year>2026</year></pub-date>
<pub-date publication-format="electronic" date-type="collection"><year>2025</year></pub-date>
<volume>12</volume><elocation-id>1740710</elocation-id>
<history>
<date date-type="received"><day>06</day><month>11</month><year>2025</year></date>
<date date-type="rev-recd"><day>22</day><month>12</month><year>2025</year></date>
<date date-type="accepted"><day>30</day><month>12</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2026 Ribic, Remme, Smiseth, Massey, Eek, Kvitting, Gullestad, Broch and Russell.</copyright-statement>
<copyright-year>2026</copyright-year><copyright-holder>Ribic, Remme, Smiseth, Massey, Eek, Kvitting, Gullestad, Broch and Russell</copyright-holder><license><ali:license_ref start_date="2026-01-22">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license>
</permissions>
<abstract><sec><title>Background and aims</title>
<p>Conventional echocardiographic measurements like ejection fraction (EF) and global longitudinal strain (GLS) evaluate left ventricular (LV) function without considering concurrent loading conditions. A more comprehensive characterization of cardiac function and energetics can be achieved through pressure-volume analysis, but its clinical application is limited by the requirement for invasive measurements. We aimed to develop a clinically accessible, non-invasive method for pressure-volume loop analysis.</p>
</sec><sec><title>Methods</title>
<p>We obtained simultaneous 3-dimensional echocardiograms and invasive LV pressures with micromanometer-tipped catheters during transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. Volume-time traces from the echocardiograms were combined with invasive LV pressures and non-invasive pressure estimates to construct pressure-volume loops. We used echocardiograms before and after TAVR to evaluate changes in myocardial function via non-invasive pressure-volume studies.</p>
</sec><sec><title>Results</title>
<p>In same-beat comparisons, stroke work calculated using non-invasive LV pressure estimations correlated well with stroke work calculated using invasive LV pressures (<italic>r</italic>&#x2009;&#x003D;&#x2009;0.95, ICC&#x2009;&#x003D;&#x2009;0.95, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001, <italic>y</italic>&#x2009;&#x003D;&#x2009;0.90X&#x2009;&#x002B;&#x2009;1,836, mean bias &#x2212;549&#x2005;mmHg&#x002A;mL, standard deviation 774&#x2005;mmHg&#x002A;mL; 95&#x0025; limits of agreement: &#x2212;2,006 to &#x002B;967&#x2005;mmHg&#x002A;mL). After TAVR, stroke work fell substantially, ventricular efficiency increased, ventriculo-arterial coupling improved, and both total and resting energy consumption decreased. On the other hand, LV biplane EF and GLS remained unchanged.</p>
</sec><sec><title>Conclusions</title>
<p>This study confirms the validity and clinical accessibility of non-invasive pressure-volume loop analysis in patients with aortic stenosis. The method identified and characterized changes in myocardial energetics, function, and ventriculo-arterial interaction, that are not typically detected by conventional echocardiography. These findings highlight the potential of non-invasive pressure-volume analysis in clinical and research practice.</p>
</sec>
</abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title>
<p>
<fig position="anchor">
<caption><p>Study design. Key Findings. Conclusion. LVP, Left ventricular pressure; 2-3DE, two- and three-dimensional echocardiography; TAVR, transcatheter aortic valve replacement; PVL, pressure-volume loop; ICC, intra-class correlation coefficient.</p></caption>
<graphic xlink:href="fcvm-12-1740710-ga001.tif" position="anchor"><alt-text content-type="machine-generated">Synopsis of study design: simultaneous measurements of invasive LVP using a micromanometer-tip catheter and of 2DE/3DE echocardiography were performed immediately before TAVR. Individual pressure&#x2013;volume loops were generated by combining LV volume-time traces from 3DE with invasive and non-invasive LVP measurements. Key findings show a high correlation and agreement between invasive and noninvasive stroke work. The conclusion highlights assessment of myocardial function before and after TAVR using noninvasive pressure&#x2013;volume analysis. Graphs illustrate the data and findings.</alt-text>
</graphic>
</fig></p>
</abstract>
<kwd-group>
<kwd>aortic stenosis</kwd>
<kwd>load dependency</kwd>
<kwd>myocardial energetics</kwd>
<kwd>pressure-volume loops</kwd>
<kwd>ventricular function</kwd>
</kwd-group><funding-group><funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was funded by Oslo University Hospital.</funding-statement></funding-group><counts>
<fig-count count="7"/>
<table-count count="2"/><equation-count count="0"/><ref-count count="20"/><page-count count="14"/><word-count count="0"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Cardiovascular Imaging</meta-value></custom-meta></custom-meta-group>
</article-meta>
</front>
<body><sec id="s1" sec-type="intro"><title>Introduction</title>
<p>Aortic stenosis (AS) is characterized by a progressive increase in left ventricular (LV) afterload, which leads to hypertrophic remodeling (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Simultaneously, contractile work and total oxygen consumption increase to maintain stroke volume (<xref ref-type="bibr" rid="B3">3</xref>). Conventional echocardiography has limited ability to assess the adaptive changes of LV function in this setting. Deformation indices used to assess systolic function and performance, such as ejection fraction (EF) and global longitudinal strain (GLS), are inherently load-dependent (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>) and do not account for concurrent loading conditions. Consequently, they fail to accurately reflect the increased myocardial work (<xref ref-type="bibr" rid="B6">6</xref>) and oxygen demand associated with elevated afterload. They also struggle to determine whether changes in measurements are due to alterations in myocardial properties or result from modifications in hemodynamics conditions. Therefore, there is a need for additional tools to assess LV function and energetics in the clinical setting while taking loading conditions into consideration.</p>
<p>Previously, we have shown that the myocardial work index (MWI) can be assessed non-invasively in patients with AS (<xref ref-type="bibr" rid="B7">7</xref>). This method uses pressure-strain loops to evaluate regional and global myocardial work. MWI accounts for afterload and reflects invasively determined myocardial work and oxygen demand (<xref ref-type="bibr" rid="B8">8</xref>). Notwithstanding, a significant limitation of the MWI is that it uses relative dimensions (strains), while physical work is based on absolute dimensions.</p>
<p>A more comprehensive understanding of myocardial function can be achieved through pressure-volume loop analysis (<xref ref-type="bibr" rid="B9">9</xref>). Here, concurrent ventricular loading conditions are integrated to characterize myocardial function and performance, while also providing insights into overall myocardial energy consumption (<xref ref-type="bibr" rid="B10">10</xref>). However, the construction of pressure-volume loops requires simultaneous invasive measurements of intraventricular pressure and volume (<xref ref-type="bibr" rid="B11">11</xref>), limiting its clinical use.</p>
<p>This study had two goals. First, we aimed to validate a novel, non-invasive method for pressure-volume analysis with potential for implementation in clinical practice. For this purpose, we used three-dimensional (3D) echocardiography and non-invasive LV pressure estimates (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). We investigated the validity of this concept in patients with severe AS who had simultaneous invasive pressure measurements and echocardiography during transcatheter aortic valve replacement (TAVR). Second, we aimed to investigate the clinical feasibility of a fully non-invasive pressure-volume analysis in patients treated for severe AS. To achieve this goal, we obtained bedside echocardiograms at the time of admission for TAVR and again at 3-month follow-up.</p>
</sec>
<sec id="s2"><title>Material and methods</title>
<p>Among 20 patients with severe AS and preserved LV EF who participated in a study where we simultaneously obtained invasive pressure measurements and echocardiograms during TAVR (<xref ref-type="bibr" rid="B7">7</xref>), we included those with available and adequate 3D-echocardiography recordings. Patients with bicuspid valve or moderate or severe valvular disease other than aortic stenosis were excluded from the study. We acquired echocardiograms at admission for TAVR, during the procedure itself, and at a 3-month follow-up after TAVR. For validation purposes, invasive pressure measurements and echocardiograms were performed simultaneously, just prior to valve implantation during the TAVR procedure. Patients were screened to ensure that acceptable ultrasound image quality was achieved while they were in the supine position.</p>
<p>The Norwegian Regional Committee for Medical Research Ethics approved the study protocol. All subjects provided written informed consent.</p>
<sec id="s2a"><title>Invasive validation of pressure-volume estimates</title>
<sec id="s2a1"><title>Echocardiography and hemodynamic measurements</title>
<p>The periprocedural echocardiograms comprised apical two-dimensional (2D) views for speckle-tracking and 3D recordings for volume assessments (Vivid E95; GE Vingmed Ultrasound, Horten, Norway). Continuous-wave (CW) Doppler was used to assess aortic valve pressure gradients and to determine precise timing of aortic valvular events. Narrow-sector, zoomed 2D images acquired at optimized frame rates were used to determine the timing of mitral valve events. Invasive measurements of LV pressures were acquired with a micromanometer-tipped catheter (Millar Micro-Tip SPC-454F, Houston, TX, USA). Brachial blood pressure was measured with a sphygmomanometer while the patient was supine.</p>
</sec>
<sec id="s2a2"><title>Non-invasive left ventricular pressure estimation</title>
<p>The method for estimating individual LV pressure waveforms has been previously described and thoroughly validated for use in patients with and without aortic stenosis (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). In brief, a generic reference LV pressure curve has been constructed by averaging and normalizing individual LV pressure tracings from patients with different heart conditions. This reference curve is scaled vertically and horizontally to coincide with estimated peak LV pressure and measured valvular events in the individual patient. For patients without significant outflow obstruction, LV peak pressure corresponds to the brachial systolic cuff pressure (<xref ref-type="bibr" rid="B8">8</xref>). For patients with AS, estimated LV peak pressure is the sum of the brachial systolic cuff pressure and the mean aortic transvalvular gradient (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B12">12</xref>). Finally, the reference curve is adjusted so that the pressure at aortic valve opening equals the diastolic cuff pressure (<xref ref-type="bibr" rid="B7">7</xref>) (<xref ref-type="fig" rid="F1">Figures&#x00A0;1A,B</xref>).</p>
<fig id="F1" position="float"><label>Figure&#x00A0;1</label>
<caption><p>Non-invasive left ventricular pressure estimation and myocardial work calculations. Panels <bold>A</bold> and <bold>B</bold>: Schematic illustration depicting transition from a standardized reference curve (blue) to an estimated individualized left ventricular pressure waveform trace (red). Panel <bold>C</bold>: Myocardial work index, represented by the area of the pressure-strain loop and related indices.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g001.tif"><alt-text content-type="machine-generated">Panel A shows a normalized left ventricular pressure curve with averaged time intervals, indicating mitral and aortic valve events. Panel B presents an estimated left ventricular pressure curve modeled from individually measured noninvasive brachial systolic and diastolic blood pressures, the mean transaortic pressure gradient derived from continuous-wave Doppler echocardiography, and individually measured valvular time intervals. Panel C depicts a pressure&#x2013;strain loop used to derive myocardial work indices, with accompanying text defining global work index, constructive work, wasted work, and work efficiency.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2a3"><title>Pressure-volume loop analysis</title>
<p>During the TAVR procedure, we simultaneously obtained shared recordings of LV volume using 3D-echocardiography and LV pressure through catheterization. The commercially available echocardiography analysis software EchoPAC (GE Vingmed Ultrasound, Horten, Norway) was utilized to measure LV volumes, allowing us to retrieve patient-specific LV volume-time traces that facilitated the construction of pressure-volume loops in this study. These measurements shared the same ECG trace, ensuring precise synchronization of LV volume and pressure. During the same periprocedural interval, brachial cuff pressure was measured using a sphygmomanometer. Mitral valvular events were assessed by 2D echocardiography, and gradients across the aortic valve together with the timing of aortic valvular were measured using CW Doppler. This allowed for the non-invasive estimation of LV pressure waveforms, as described above. By combining the LV volume-time traces with invasively measured and non-invasively estimated LV pressure waveforms, we created two sets of pressure-volume loops: one that incorporated invasively recorded LV pressures another that was fully non-invasive. Given that the invasive pressure measurements were done simultaneously with the 3D-echocardiograms and the brachial blood pressure measurement, same-beat comparisons of LV pressure&#x2013;volume loops based on invasively measured LV pressure and non-invasive LV pressure estimates could be performed. This allowed us to evaluate the accuracy of non-invasive pressure&#x2013;volume analysis (<xref ref-type="fig" rid="F2">Figure&#x00A0;2</xref>).</p>
<fig id="F2" position="float"><label>Figure&#x00A0;2</label>
<caption><p>Constructing a pressure-volume loop. The upper panel: An individual volume-time trace measured with 3D-echocardiography, along simultaneously measured left ventricular pressure (LVP) (red) and non-invasive estimation of LVP (blue). The lower panel: Synchronized integration of pressures and volumes generates individual pressure-volume loops for direct same-beat comparison.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g002.tif"><alt-text content-type="machine-generated">Construction of pressure&#x2013;volume loops. The top-left panel shows an individual volume-time trace derived from 3D echocardiography. The top-right panel compares invasively measured and non-invasively estimated left ventricular pressures in the same subject. The bottom panel displays the derived pressure&#x2013;volume loops, comparing loops obtained using invasive and noninvasive LV pressure estimates.</alt-text>
</graphic>
</fig>
<p>From the pressure&#x2013;volume loops, stroke work was estimated as the area enclosed by each loop. Estimate of ventricular contractility, end-systolic elastance, was obtained from the slope of the end-systolic pressure&#x2013;volume relationship, defined as the line connecting the end-systolic pressure point on the loop to the volume axis at an arbitrary intercept V0, where V0&#x2009;&#x003D;&#x2009;0&#x2005;mL. The end-systolic point on each loop was identified as the point in the upper-left region of the loop with the greatest normalized distance from the loop&#x0027;s geometric center.</p>
<p>We did not explicitly define an end-diastolic point on the loop because it was not incorporated in any specific calculations; however, end-diastolic volume, defined as the chamber&#x0027;s maximum volume, was used in several analyses. Ventricular afterload expressed as end-arterial elastance, calculated as the ratio of end-systolic pressure to stroke volume. End-diastolic volume was also used to compute single-beat contractility indices: the ratio of end-systolic pressure to end-diastolic volume and the ratio of maximum systolic pressure to end-diastolic volume. Ventriculo-arterial coupling, which describes the interaction between ventricular contractility and the arterial system, was expressed as the ratio end-arterial elastance to end-systolic elastance. Finally, ventricular efficiency was assessed by expressing stroke work relative to the total pressure&#x2013;volume area (<xref ref-type="fig" rid="F3">Figure&#x00A0;3</xref>).</p>
<fig id="F3" position="float"><label>Figure&#x00A0;3</label>
<caption><p>Schematic presentation of non-invasive pressure-volume analysis. Panel <bold>A</bold>: Cardiac cycle phases, valvular events, and <italic>Stroke Volume</italic> (SV) are illustrated on the pressure-volume (PV) loop, with the enclosed area representing <italic>Stroke Work</italic> (SW). Panel <bold>B</bold>: Ventricular contractility is expressed by the end-systolic elastance (Ees), the slope of the <italic>end-systolic pressure-volume relationship</italic> (ESPVR), and the one-beat contractility index ESP/EDV. The ESPVR line connects the point of <italic>end-systolic pressure</italic> (ESP) on the loop and the volume axis at an intercept (V0) where pressure equals to zero. V0 should ideally be found from multiple loops during preload constriction, but in our one-beat approach it is set to the origin. A leftward and upward shift of the ESPVR line enhances end-systolic elastance and the ESP/EDV ratio, reflecting an increase in contractility. The interaction between ventricular contractility and the arterial system, known as ventriculo-arterial coupling, is represented by the ratio of arterial elastance to end-systolic elastance. Arterial elastance serves as a surrogate measure of ventricular afterload, reflecting extra cardiac forces that oppose stroke volume ejection by relating end-systolic pressure to stroke volume. Panel <bold>C</bold>: Change in intraventricular pressure relative to volume during diastole defines the non-linear <italic>end-diastolic pressure-volume relationship</italic> (EDPVR), Characterizing passive mechanical properties through stiffness (&#x0394; pressure/&#x0394; volume) and compliance (&#x0394; volume/&#x0394; pressure). Panel <bold>D</bold>: The <italic>pressure-volume area</italic> (PVA) is the sum of <italic>stroke work</italic> and <italic>potential energy (PE), representing</italic> the total amount of mechanical energy generated during a cardiac cycle. Potential energy represents the energy stored in the ventricle at the end of systole, and is illustrated on the diagram by the area enclosed by the ESPVR line, the isovolumetric relaxation line, and the EDPVR line. It is directly influenced by the position of the PV-loop along and differentiates the various contributors to ventricular energy consumption, enabling expression of <italic>ventricular efficiency</italic> as the ratio of stroke volume and the total pressure-volume area.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g003.tif"><alt-text content-type="machine-generated">Four-panel figure showing cardiac function and energetics as assessed with pressure-volume studies. Panel A: Pressure-volume loop with labeled cardiac cycle phases, valve events, stroke work and volume. Panel B: Ventricular contractility, afterload and ventriculo-arterial coupling when assessed with pressure-volume studies. Panel C: Graph displaying ventricular passive properties with the EDPVR curve in relation to a pressure-volume loop. Panel D: Pressure-volume loop in regard to ventricular energetics; potential energy, total mechanical energy depicted by total pressure-volume area and ventricular efficiency.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s2b"><title>Ventricular function before and after TAVR</title>
<sec id="s2b1"><title>Non-invasive pressure-volume studies</title>
<p>At <bold><italic>baseline</italic></bold> (admission for TAVR), LV pressure waveforms were estimated while accounting for the mean transaortic pressure gradient in patients with severe AS. At the 3-month outpatient <bold><italic>follow-up</italic></bold> the LV pressure waveforms ware computed without including the transaortic gradient. These estimated pressure traces were then combined with corresponding baseline and follow-up LV volume traces in the same manner as the data acquired in the catheterization lab. This approach enabled us to create fully non-invasive, individualized pressure-volume loops for the patients at these two distinct time points.</p>
</sec>
<sec id="s2b2"><title>Myocardial work index</title>
<p>Global myocardial work index, constructive and wasted work, and myocardial work efficiency were calculated by integrating LV pressure curves estimated non-invasively, as described earlier, with segmental strain traces obtained from 2D speckle-tracking GLS analysis using commercially available EchoPAC (GE Vingmed Ultrasound, Horten, Norway) (<xref ref-type="bibr" rid="B13">13</xref>) (<xref ref-type="fig" rid="F1">Figure&#x00A0;1C</xref>).</p>
</sec>
</sec>
<sec id="s2c"><title>Statistical analysis</title>
<p>Values are expressed as mean&#x2009;&#x00B1;&#x2009;standard deviation unless otherwise specified. We compared methods of measurement using least-squares linear regression, Pearson correlation coefficients, intra-class correlation coefficients (ICCs) with consistency of agreement based on a two-way mixed-effect model, and Bland&#x2013;Altman plots with calculations of limits of agreement. Paired <italic>t</italic>-test was used for parametric data sets and the Wilcoxon rank-sum test for non-parametric data sets. Inter- and intraobserver variability for estimated non-invasive stroke work (the enclosed area of the pressure&#x2013;volume loop) were assessed by reanalyzing ten randomly selected examinations from the clinical proof-of-concept cohort by two independent raters (A and B). Interobserver variability was evaluated using a two-way random-effects model, and intraobserver variability using a one-way random-effects model; agreement was also examined with Bland&#x2013;Altman analysis.</p>
<p>Statistical analysis was performed with STATA SE 16.0 (StataCorp, College Station, TX, USA) and GraphPad Prism version 9.0.0 (Windows, GraphPad Software, Boston, Massachusetts USA, <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results"><title>Results</title>
<p>All of the 20 patients included in the original study (<xref ref-type="bibr" rid="B7">7</xref>) underwent echocardiography at admission as well as periprocedural echocardiography with simultaneous invasive intraventricular pressure recordings immediately before the TAVR. Follow-up echocardiograms were obtained in 19 patients 3.6&#x2009;&#x00B1;&#x2009;0.7 months after the procedure. One patient declined evaluation due to the ongoing Covid-19 pandemic (<xref ref-type="sec" rid="s13">Supplementary Figure 1</xref>). Determination of aortic and mitral valve events was feasible in all patients, as was successful non-invasive estimation of the LV pressure waveforms.</p>
<sec id="s3a"><title>Invasive validation of pressure-volume studies</title>
<p>Successful recordings of LV volume-time traces and simultaneous invasive pressure measurements, obtained immediately before the implantation of the aortic valve prosthesis and deemed adequate for further analysis, were available for 16 of the 20 study subjects. These 16 patients were all in sinus rhythm and constituted our <bold><italic>validation cohort</italic></bold>.</p>
<p>We used multi-beat real-time 3D-echocardiography to obtain LV time-volume traces. In four patients, the image frame rate was below 12&#x2005;frames per s, which hindered the successful generation of volume-time traces. In the remaining 16 patients, the average frame rate for the 3D LV studies was 31&#x2009;&#x00B1;&#x2009;0&#x2005;frames per s. The validity of the non-invasive pressure-volume analysis was tested by same beat comparison in these 16 patients.</p>
<p>The fully non-invasive stroke work estimates, expressed as the area enclosed by the pressure-volume loop constructed from 3D-echocardiograms and non-invasively estimated LV pressure corresponded well with the stroke work calculated by invasively measured LV pressure. There was excellent correlation, good fit (<italic>r</italic>&#x2009;&#x003D;&#x2009;0.95, ICC&#x2009;&#x003D;&#x2009;0.95, <italic>y</italic>&#x2009;&#x003D;&#x2009;0.90<italic>X</italic>&#x2009;&#x002B;&#x2009;1,836, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001) between the stroke work as appraised by the two methods with a strong agreement relative to the mean stroke work of 13,070&#x2009;&#x00B1;&#x2009;2,417&#x2005;mmHg&#x002A;mL: mean bias &#x2212;549&#x2005;mmHg&#x002A;mL, standard deviation 774&#x2005;mmHg&#x002A;mL; 95&#x0025; limits of agreement: &#x2212;2,006 to &#x002B;967&#x2005;mmHg&#x002A;mL (<xref ref-type="fig" rid="F4">Figure&#x00A0;4</xref>).</p>
<fig id="F4" position="float"><label>Figure&#x00A0;4</label>
<caption><p>Comparison of stroke work values derived from invasive vs. non-invasive LV pressure assessment. <bold>(A)</bold> Correlation and <bold>(B)</bold> agreement of stroke work, determined by the area enclosed within the pressure-volume loop, based on measured <italic>invasive</italic> and <italic>estimated</italic> left ventricular pressures. ICC, intra-class correlation coefficient.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g004.tif"><alt-text content-type="machine-generated">Graph A is a scatter plot showing a positive correlation between invasive and non-invasive stroke work with a linear regression line. The equation is y = 0.90x &#x002B; 1836, ICC = 0.95, r = 0.95, and p &#x003C; 0.0001. Graph B is a Bland-Altman plot displaying the difference between non-invasive and invasive stroke work against their average. It indicates a mean bias of -549 mmHg&#x002A;ml and 95% limits of agreement from -2006 to 967 mmHg&#x002A;ml.</alt-text>
</graphic>
</fig>
<p>Similarly, we observed good correlation and a good fit with strong agreement between parameters derived from pressure-volume loops constructed from non-invasive LV pressure estimates and those based on invasively measured pressures. LV end-systolic elastance, end-arterial elastance, ventricular efficiency, ventriculo-arterial coupling, and potential energy as assessed by pressure-volume loops based on estimated pressures all correlated strongly with those based on invasive measurements (<xref ref-type="fig" rid="F5">Figure&#x00A0;5</xref>).</p>
<fig id="F5" position="float"><label>Figure&#x00A0;5</label>
<caption><p>Correlation and agreement of metrics derived from the pressure-volume analysis based on invasive measurements and non-invasive estimates of LV pressures. ICC, intra-class correlation coefficient.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g005.tif"><alt-text content-type="machine-generated">Multiple scatter plots and Bland-Altman plots compare invasive and non-invasive measurements of cardiovascular parameters: End-Systolic Elastance (Ees), End-Systolic Pressure/End-Diastolic Volume (ESP/EDV), End-Arterial Elastance (Ea), Ventriculo-Arterial Coupling (Ea/Ees), Ventricular Efficiency, and Potential Energy (PE). Each plot shows strong correlations, with bias and limits of agreement annotated. The correlations are statistically significant with respective p-values provided.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3b"><title>Ventricular function before and after the TAVR procedure</title>
<p>Successful paired non-invasive pressure-volume analysis was achieved at the time of admission and at the 3-month follow-up in 17 of the 20 patients; all 17 were in sinus rhythm. These analyses formed our <bold><italic>clinical proof-of-concept cohort</italic></bold> and allowed for further investigation of potential changes in ventricular properties associated with TAVR. <xref ref-type="table" rid="T1">Table&#x00A0;1</xref> presents baseline demographic characteristics for this cohort. Volume analysis by 3D-echocardiography was not feasible in one patient at baseline and in two patients at follow-up due to technical issues related to heartbeat variability at the time of examination. Additionally, one patient was lost to follow-up, which has already been noted.</p>
<table-wrap id="T1" position="float"><label>Table&#x00A0;1</label>
<caption><p>Baseline characteristics (<italic>n</italic>&#x2009;&#x003D;&#x2009;17).</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left" colspan="2">Variable</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Sex (<italic>n</italic>,&#x0025;)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">&#x2003;Female</td>
<td valign="top" align="center">10 (59&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Age (years)</td>
<td valign="top" align="center">77&#x2009;&#x00B1;&#x2009;5</td>
</tr>
<tr>
<td valign="top" align="left">Body mass index (kg/m<sup>2</sup>)</td>
<td valign="top" align="center">26.4&#x2009;&#x00B1;&#x2009;4.4</td>
</tr>
<tr>
<td valign="top" align="left">Hypertension (<italic>n</italic>,&#x0025;)</td>
<td valign="top" align="center">16 (94&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Coronary artery disease (<italic>n</italic>,&#x0025;)</td>
<td valign="top" align="center">11 (65&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Diabetes mellitus (<italic>n</italic>,&#x0025;)</td>
<td valign="top" align="center">2 (12&#x0025;)</td>
</tr>
<tr>
<td valign="top" align="left">Systolic blood pressure (mmHg)</td>
<td valign="top" align="center">159&#x2009;&#x00B1;&#x2009;28</td>
</tr>
<tr>
<td valign="top" align="left">Diastolic blood pressure (mmHg)</td>
<td valign="top" align="center">73&#x2009;&#x00B1;&#x2009;12</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF1"><p>Values are reported as mean&#x2009;&#x00B1;&#x2009;standard deviation for continuous variables, and <italic>n</italic> (&#x0025;) for categorical variables.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Calculation of the MWI was feasible in all patients who underwent conventional 2D-echocardiography and Doppler measurements at baseline (<italic>n</italic>&#x2009;&#x003D;&#x2009;20) and at follow up (<italic>n</italic>&#x2009;&#x003D;&#x2009;19). To compare the conventional echocardiographic and MWI indices with parameters derived from non-invasive pressure-volume analysis, we excluded data from patients who did not have paired non-invasive pressure-volume measurements at both baseline and follow-up. Thus, we present data for the 17 patients with paired datasets at both time points.</p>
<p>The results of conventional echocardiograms, MWI, and non-invasive pressure-volume studies before and following TAVR are presented in <xref ref-type="table" rid="T2">Table&#x00A0;2</xref> and <xref ref-type="fig" rid="F6">Figure&#x00A0;6</xref>. The systolic blood pressure was 159&#x2009;&#x00B1;&#x2009;28&#x2005;mmHg at baseline compared to 159&#x2009;&#x00B1;&#x2009;17&#x2005;mmHg at follow-up, with mean difference 0&#x2009;&#x00B1;&#x2009;25&#x2005;mmHg, (<italic>p</italic>&#x2009;&#x003D;&#x2009;0.96). While there was no significant change in mass or end-diastolic intracavitary diameter, there was a significant reduction of systolic and diastolic volumes from baseline to follow-up. Systolic function, as assessed by 3D EF, improved slightly. Notably, there were no statistically significant changes in 2D EF or GLS. In contrast, we observed substantial changes for myocardial work indices as well as for metrics derived from pressure-volume loops. We observed a reduction of &#x2212;855&#x2005;mmHg&#x0025;&#x2009;&#x00B1;&#x2009;471&#x2005;mmHg&#x0025; and &#x2212;854&#x2005;mmHg&#x0025;&#x2009;&#x00B1;&#x2009;582&#x2005;mmHg&#x0025; for MWI and constructive myocardial work, respectively. There was also a substantial and significant reductions in stroke work of &#x2212;4,280&#x2005;mmHg&#x002A;mL&#x2009;&#x00B1;&#x2009;2,124&#x2005;mmHg&#x002A;mL, and in potential energy &#x2212;4,256&#x2005;mmHg&#x002A;mL&#x2009;&#x00B1;&#x2009;1,886&#x2005;mmHg&#x002A;mL. Furthermore, there was a significant reduction in end-arterial elastance expressing afterload (mean difference&#x2014;0.4&#x2009;&#x00B1;&#x2009;0.3), and contractility expressed by the ratio of end-systolic pressure to end-diastolic volume (mean difference&#x2014;0.1&#x2009;&#x00B1;&#x2009;0.1). End-systolic elastance also decreased, but the change was not statistically significant. Ventriculo-arterial coupling improved, with a relative reduction of 13&#x0025;, indicating a more optimal interaction between the ventricle and arterial system, and ventricular efficiency improved by 1.8&#x0025;&#x2009;&#x00B1;&#x2009;3.1&#x0025;. Both changes were statistically significant.</p>
<table-wrap id="T2" position="float"><label>Table&#x00A0;2</label>
<caption><p>Conventional and novel echocardiographic parameters at admission and follow-up (<italic>n</italic>&#x2009;&#x003D;&#x2009;17).</p></caption>
<table>
<colgroup>
<col align="left"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup>
<thead>
<tr>
<th valign="top" align="left">Conventional echocardiographic parameters</th>
<th valign="top" align="center">Baseline</th>
<th valign="top" align="center">Follow-up</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">LV end-diastolic diameter (cm)</td>
<td valign="top" align="center">4.7&#x2009;&#x00B1;&#x2009;0.6</td>
<td valign="top" align="center">4.6&#x2009;&#x00B1;&#x2009;0.5</td>
<td valign="top" align="center">0.540</td>
</tr>
<tr>
<td valign="top" align="left">LV mass index 2D (g/m2)</td>
<td valign="top" align="center">84&#x2009;&#x00B1;&#x2009;23</td>
<td valign="top" align="center">76&#x2009;&#x00B1;&#x2009;17</td>
<td valign="top" align="center">0.083</td>
</tr>
<tr>
<td valign="top" align="left">LV end-diastolic volume 2D (mL)</td>
<td valign="top" align="center">170&#x2009;&#x00B1;&#x2009;41</td>
<td valign="top" align="center">148&#x2009;&#x00B1;&#x2009;35</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LV end-systolic volume 2D (mL)</td>
<td valign="top" align="center">77&#x2009;&#x00B1;&#x2009;21</td>
<td valign="top" align="center">63&#x2009;&#x00B1;&#x2009;15</td>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="left">LV end-diastolic volume 3D (mL)</td>
<td valign="top" align="center">172&#x2009;&#x00B1;&#x2009;40</td>
<td valign="top" align="center">148&#x2009;&#x00B1;&#x2009;36</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LV end-systolic volume 3D (mL)</td>
<td valign="top" align="center">79&#x2009;&#x00B1;&#x2009;20</td>
<td valign="top" align="center">64&#x2009;&#x00B1;&#x2009;17</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">LV stroke volume 3D (mL)</td>
<td valign="top" align="center">93&#x2009;&#x00B1;&#x2009;23</td>
<td valign="top" align="center">84&#x2009;&#x00B1;&#x2009;22</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">LV ejection fraction 2D (&#x0025;)</td>
<td valign="top" align="center">55&#x2009;&#x00B1;&#x2009;3</td>
<td valign="top" align="center">57&#x2009;&#x00B1;&#x2009;4</td>
<td valign="top" align="center">0.123</td>
</tr>
<tr>
<td valign="top" align="left">LV ejection fraction 3D (&#x0025;)</td>
<td valign="top" align="center">54&#x2009;&#x00B1;&#x2009;4</td>
<td valign="top" align="center">57&#x2009;&#x00B1;&#x2009;5</td>
<td valign="top" align="center">0.029</td>
</tr>
<tr>
<td valign="top" align="left">Aortic valve velocity (m/s)</td>
<td valign="top" align="center">4.6&#x2009;&#x00B1;&#x2009;0.5</td>
<td valign="top" align="center">2.2&#x2009;&#x00B1;&#x2009;0.5</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Aortic transvalvular mean gradient (mmHg)</td>
<td valign="top" align="center">51&#x2009;&#x00B1;&#x2009;13</td>
<td valign="top" align="center">11&#x2009;&#x00B1;&#x2009;5</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Heart rate (beats per min)</td>
<td valign="top" align="center">67&#x2009;&#x00B1;&#x2009;18</td>
<td valign="top" align="center">64&#x2009;&#x00B1;&#x2009;10</td>
<td valign="top" align="center">0.854</td>
</tr>
<tr>
<td valign="top" align="left">Global longitudinal strain (&#x0025;)</td>
<td valign="top" align="center">16.5&#x2009;&#x00B1;&#x2009;2.3</td>
<td valign="top" align="center">17.0&#x2009;&#x00B1;&#x2009;2.4</td>
<td valign="top" align="center">0.369</td>
</tr>
<tr>
<th valign="top" align="left">Myocardial work index parameters</th>
<th valign="top" align="center">Baseline</th>
<th valign="top" align="center">Follow-up</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
<tr>
<td valign="top" align="left">Global work index (mmHg&#x0025;)</td>
<td valign="top" align="center">3,208&#x2009;&#x00B1;&#x2009;519</td>
<td valign="top" align="center">2,353&#x2009;&#x00B1;&#x2009;475</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Global constructive work (mmHg&#x0025;)</td>
<td valign="top" align="center">3,549&#x2009;&#x00B1;&#x2009;619</td>
<td valign="top" align="center">2,696&#x2009;&#x00B1;&#x2009;469</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Global wasted work (mmHg&#x0025;)</td>
<td valign="top" align="center">128&#x2009;&#x00B1;&#x2009;58</td>
<td valign="top" align="center">132&#x2009;&#x00B1;&#x2009;74</td>
<td valign="top" align="center">0.859</td>
</tr>
<tr>
<td valign="top" align="left">Global work efficiency (&#x0025;)</td>
<td valign="top" align="center">96.0&#x2009;&#x00B1;&#x2009;1.8</td>
<td valign="top" align="center">94.6&#x2009;&#x00B1;&#x2009;3.0</td>
<td valign="top" align="center">0.125</td>
</tr>
<tr>
<th valign="top" align="left">Pressure-volume analysis parameters</th>
<th valign="top" align="center">Baseline</th>
<th valign="top" align="center">Follow-up</th>
<th valign="top" align="center"><italic>P</italic>-value</th>
</tr>
<tr>
<td valign="top" align="left">Stroke Work (mmHg&#x002A;mL)</td>
<td valign="top" align="center">13,182&#x2009;&#x00B1;&#x2009;3,234</td>
<td valign="top" align="center">8,902&#x2009;&#x00B1;&#x2009;2,249</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">End-Systolic Elastance (mmHg/mL)</td>
<td valign="top" align="center">2.36&#x2009;&#x00B1;&#x2009;0.75</td>
<td valign="top" align="center">2.22&#x2009;&#x00B1;&#x2009;0.60</td>
<td valign="top" align="center">0.099</td>
</tr>
<tr>
<td valign="top" align="left">Arterial Elastance (mmHg/mL)</td>
<td valign="top" align="center">2.65&#x2009;&#x00B1;&#x2009;0.63</td>
<td valign="top" align="center">2.22&#x2009;&#x00B1;&#x2009;0.60</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Ventricular Efficiency (&#x0025;)</td>
<td valign="top" align="center">53.7&#x2009;&#x00B1;&#x2009;3.3</td>
<td valign="top" align="center">55.5&#x2009;&#x00B1;&#x2009;2.5</td>
<td valign="top" align="center">0.027</td>
</tr>
<tr>
<td valign="top" align="left">End-Systolic Pressure/End-Diastolic Volume (mmHg/mL)</td>
<td valign="top" align="center">1.24&#x2009;&#x00B1;&#x2009;0.32</td>
<td valign="top" align="center">1.10&#x2009;&#x00B1;&#x2009;0.28</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Maximal Systolic Pressure/End-Diastolic Volume (mmHg/mL)</td>
<td valign="top" align="center">1.28&#x2009;&#x00B1;&#x2009;0.33</td>
<td valign="top" align="center">1.13&#x2009;&#x00B1;&#x2009;0.29</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Ventriculo-Arterial Coupling</td>
<td valign="top" align="center">1.17&#x2009;&#x00B1;&#x2009;0.22</td>
<td valign="top" align="center">1.01&#x2009;&#x00B1;&#x2009;0.18</td>
<td valign="top" align="center">0.013</td>
</tr>
<tr>
<td valign="top" align="left">Pressure Volume Area (mmHg&#x002A;mL)</td>
<td valign="top" align="center">24,556&#x2009;&#x00B1;&#x2009;5,950</td>
<td valign="top" align="center">16,020&#x2009;&#x00B1;&#x2009;3,915</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Potential Energy (mmHg&#x002A;mL)</td>
<td valign="top" align="center">11,374&#x2009;&#x00B1;&#x2009;2,900</td>
<td valign="top" align="center">7,118&#x2009;&#x00B1;&#x2009;1,743</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TF2"><p>Values are reported as mean&#x2009;&#x00B1;&#x2009;standard deviation. LV, left ventricular.</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="F6" position="float"><label>Figure&#x00A0;6</label>
<caption><p>Ventricular function before and after valve replacement. Baseline ventricular function at the time of admission for valve replacement (blue dots) and at follow-up after valve replacement (red dots). The left panel of each graph depicts trend of change, and the right panel the individual and mean differences. <bold>(A)</bold> Ejection Fraction with 2D-echocardiography. <bold>(B)</bold> Global Longitudinal Strain (GLS). <bold>(C)</bold> Global Work Index (GWI). <bold>(D)</bold> Stroke Work. <bold>(E)</bold> Ventricular Efficiency. <bold>(F)</bold> Potential Energy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g006.tif"><alt-text content-type="machine-generated">Six charts labeled A to F compare baseline and follow-up data on cardiac metrics: A) 2D Ejection Fraction, B) Global Longitudinal Strain, C) Global Work Index, D) Stroke Work, E) Ventricular Efficiency, F) Potential Energy. Each chart shows paired baseline and follow-up dots with mean differences. Blue represents baseline, red indicates follow-up. Differences are shown on the right side of each chart with corresponding bars and error lines.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3c"><title>Interobserver and intraobserver variability</title>
<p>Both inter- and intraobserver comparisons of stroke work measurements showed strong agreement. Mean biases were &#x2212;420&#x2005;mmHg&#x002A;mL and &#x2212;102&#x2005;mmHg&#x002A;mL, respectively, relative to the mean estimated stroke work of 13 172&#x2005;mmHg&#x002A;mL. Intraclass correlation coefficients were high for both interobserver and intraobserver variability (ICC&#x2009;&#x003D;&#x2009;0.97 for each) (<xref ref-type="sec" rid="s13">Supplementary Figure 2</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion"><title>Discussion</title>
<p>This validation and proof-of-concept study shows that non-invasive pressure-volume analysis based on 3D-echocardiography and non-invasive LV pressure estimates is feasible and attainable in patients with severe AS. We demonstrate that non-invasive pressure-volume loops and their derived parameters correlate and agree well with values obtained from invasive pressure measurements. Our findings are consistent with those of a recent study that investigated non-invasive pressure-volume analysis in an experimental animal model (<xref ref-type="bibr" rid="B14">14</xref>).</p>
<p>To our knowledge, this is the first study to directly compare beat-to-beat pressure-volume loops obtained non-invasively to pressure-volume loops derived from invasive pressures in patients with severe AS. Furthermore, our results highlight the inability of conventional deformation indexes to accurately reflect changes in LV performance under different loading conditions.</p>
<p>We investigated a small cohort of patients with severe AS. On average, the patients had slightly elevated LV volumes, normal LV internal dimensions, normal LV mass index and preserved systolic function. In these patients, we observed that the left ventricle effectively compensates for the increased afterload. As expected, and as previously reported TAVR resulted in substantial reductions in transaortic mean valve gradients, but also in a matched reduction of diastolic and systolic LV volumes (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). Reduction of LV volumes without substantial changes in intraventricular dimensions has previously been observed in patients undergoing surgical treatment for severe AS (<xref ref-type="bibr" rid="B17">17</xref>). Importantly, we did not detect any significant changes in 2D LV EF and GLS, while 3D LV EF showed a slight improvement. The systolic blood pressure remained unchanged. Interestingly, in our cohort, the benefits of outflow obstruction relief after TAVR were undetectable by conventional methods that are widely used to evaluate systolic function (<xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref>).</p>
<fig id="F7" position="float"><label>Figure&#x00A0;7</label>
<caption><p>Evaluation of ventricular function in a study patient using conventional and novel echocardiographic parameters before and after valve replacement. EF, ejection fraction; EDV, end- diastolic volume; ESV, end-systolic volume; SV, stroke volume; GLS, global longitudinal strain; GWI, global work index; GWW, global wasted work; GCW, global constructive work; GWE, global work efficiency; Ees, end-systolic elastance; Ea, end-arterial elastance; VE, ventricular efficiency; VAC, ventriculo-arterial coupling; PVA, pressure-volume area; PE, potential energy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fcvm-12-1740710-g007.tif"><alt-text content-type="machine-generated">Conventional echocardiographic indices, non-invasive myocardial-work metrics, and non-invasive pressure&#x2013;volume measurements obtained before and after TAVR are presented for a single patient. Key values include a slight change in EF and GLS, compared with a more profound change in global myocardial work and stroke work. Graphs show pressure&#x2013;strain loops and pressure&#x2013;volume loops before and after TAVR, illustrating changes in cardiac function following the procedure.</alt-text>
</graphic>
</fig>
<p>Conversely, significant changes were noted in several parameters derived from pressure-volume studies and the MWI when accounting for variations in loading conditions. After TAVR we observed statistically significant reductions in global total myocardial work and global constructive myocardial work. These findings primarily reflect the consequences of reduced workload due to the decreased afterload after valve implantation. As previously reported, the decrease in total myocardial work and constructive myocardial work did not result in significant changes in the quantity of wasted work or work efficiency (<xref ref-type="bibr" rid="B12">12</xref>), thus reflecting a synchronous deformation pattern (by strain) following TAVR.</p>
<p>The non-invasive MWI uses segmental GLS traces and LV pressure estimations to quantify regional and global myocardial work. In contrast, the non-invasive pressure-volume loop analysis incorporates intraventricular pressures and the total volume change throughout the cardiac cycle. Thus, replacing strain, a relative measure, by absolute volume. In this regard, pressure-volume analysis provides absolute measures of global LV properties, overcoming the limitations of a relative measure such as strain. This has the potential to impact on the stroke work values obtained from the two methods. For example, a dilated compensated ventricle with maintained stroke volume, but significantly reduced strain, will have a severely reduced MWI, whereas absolute values obtained from pressure-volume analysis reflect the preserved ability to provide an adequate cardiac output. The two methods illuminate different aspects of compensatory mechanisms, global and regional properties, and pattern of myocardial deformation. Hence, they have the potential to complement each other for a comprehensive evaluation of myocardial performance. This is underscored by the following observation: after TAVR, there was a greater relative reduction in stroke work, as determined by pressure-volume loop analysis, compared to the reduction in the MWI as assessed by pressure-strain loop analysis: 32&#x0025; vs. 26&#x0025;, respectively. Although the two methods demonstrated consistent change, the associated LV volume change impacted the two work estimates differently, contributing to a difference in the relative change of work estimates.</p>
<p>Following TAVR, the parameters derived from pressure-volume analysis were directly influenced by the reduction of outflow obstruction as well as by the change in LV volumes. While there were no significant changes in EF and GLS, all but one of the pressure-volume parameters changed significantly after TAVR, underscoring the sensitivity of pressure-volume analysis to detect dynamic changes in LV properties. Previous studies, conducted soon after TAVR in patients with preserved EF, have found only marginal changes in EF and GLS (<xref ref-type="bibr" rid="B18">18</xref>). Our cohort was small, and we acknowledge that this may limit the ability to detect modest changes for EF and GLS. However, it is important to contrast these findings with the substantial changes in parameters that account for loading variations within the same cohort.</p>
<p>In patients treated with TAVR, conventional echocardiographic evaluation revealed a reduction of transaortic velocities, gradients, and LV end-systolic/diastolic volumes, while conventional deformation indices used for assessing systolic function remained unchanged. The 3D LV EF assessment picked up a slight improvement in systolic function. However, changes observed after TAVR were more pronounced when integrating concurrent loading conditions. After TAVR, we observed a significant reduction in global and constructive myocardial work and a reduction in stroke work, as derived from pressure-volume studies. Furthermore, we were able to document effects of the TAVR procedure, evident by a reduction in contractile load with a reduction of end-systolic pressure to end-diastolic volume ratio and optimalisation of the ventriculo-arterial coupling (<xref ref-type="bibr" rid="B19">19</xref>) with an increase in ventricular efficiency, all while reducing potential energy. End-systolic elastance also declined; however, this decline did not reach statistical significance. The pressure-volume studies were able not only to document a reduction in cardiac work during systole, as is the case for myocardial work indices, but also shed light on important aspects regarding the resting state of the ventricle and the interaction between the ventricle and the arterial system. <xref ref-type="fig" rid="F7">Figure&#x00A0;7</xref> illustrates these observations at the individual level. It is important to note that the blood pressure remained unchanged after TAVR, suggesting that the primary drivers of change in loading conditions were the reduction in transvalvular gradient and the subsequent alterations in ventricular volume. Further studies should assess these metrics in a larger cohort of patients under varying degrees of afterload to investigate whether cumulative workload and ventricular adaptation under increasing afterload are related to the accumulation of myocardial fibrosis, and to determine how this relationship influences prognosis. In turn, these findings could inform clinical decision-making.</p>
<sec id="s4a"><title>Accessibility of the method</title>
<p>As is true for echocardiography in general, the quality of the ultrasound image is crucial for accurate assessment of LV volumes with 3D-echocardiography and the subsequent non-invasive pressure-volume analysis. In our study, the ability to acquire adequate 3D-volume studies in some patients was limited not by image quality, but by inadequate frame rates during the examination and by variations in RR-interval. Both issues are technical and can be overcome by awareness and understanding of the method.</p>
<p>Over the past two decades, 3D-echocardiography has become increasingly accessible as a bedside tool for assessing LV volumes and function. Compared with 2D-echocardiography, 3D-echocardiography provides results that are more reliable and correlate better with those obtained by cardiac magnetic resonance imaging, the gold standard for cardiac volume measurements (<xref ref-type="bibr" rid="B20">20</xref>). Unlike 2D-echocardiography, 3D-echocardiography does not rely on geometric assumptions about LV shape and avoids foreshortening, while achieving acceptable intra- and interobserver reproducibility (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>The method for estimating non-invasive LV pressures was successful in all study subjects and the validity of this approach is well-established (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>). Our validation cohort consisted of patients with severe AS. However, the method for non-invasive pressure-volume loop analysis, as outlined in this study, can also be applied to patients without outflow obstruction. In such cases, the estimation of LV pressure relies solely on the brachial systolic blood pressure, without the need to incorporate the mean trans-aortic pressure gradient.</p>
<p>The described method is based on data that are readily available using commercial software, and it showed strong correlation and agreement with respect to inter- and intraobserver variability. This suggests that the integration of non-invasive pressure estimates and volumes could be streamlined to become an integral part of the routine LV work-up.</p>
</sec>
</sec>
<sec id="s5"><title>Limitations</title>
<p>Non-invasive pressure-volume loop analysis as proposed herein is a clinically oriented single-beat method of calculating specific ventricular metrics that incorporate actual loading conditions. The method offers parameter estimates derived from pressure-volume loops that differ from those obtained through traditional invasive pressure-volume studies. Here, multiple recordings under varying loading conditions are recorded and analyzed to determine contractile and passive properties of the left ventricle. This is neither possible nor practical in the bedside setting. Furthermore, the method does not take heart rate into account: therefore, changes in volume and absolute values derived from pressure-volume studies must be evaluated with this in mind. The method operates with absolute values that require normalization for comparison between individual patients. As previously documented (<xref ref-type="bibr" rid="B7">7</xref>), our method for estimating LV pressure tends to overestimate filling pressures when LV systolic pressure is substantially elevated. Acknowledging the model&#x0027;s limited accuracy during the filling phase, we therefore did not assess the end-diastolic pressure&#x2013;volume relationship in this study. In patients with very high systolic pressure, the model also underestimates pressure&#x2013;volume loop area relative to true values resulting in an underestimation of stroke work. This discrepancy is less pronounced at normal LV pressures.</p>
<p>We have arbitrarily set the V0, the theoretical LV volume at zero pressure, to zero. Therefore, our definition of the end-systolic pressure-volume relationship differs from the classical assumption. This influences the calculations of ventriculo-arterial coupling, end-systolic elastance, potential energy and ventricular efficiency. True V0 will always be a positive, finite volume. Hence, the non-invasive end-systolic elastance value with V0&#x2009;&#x003D;&#x2009;0&#x2005;mL will be lower compared to its true value.</p>
</sec>
<sec id="s6" sec-type="conclusions"><title>Conclusion</title>
<p>This study confirms the feasibility of a non-invasive method of pressure-volume loop analysis using concurrent 3D-echocardiography LV volumes and non-invasive LV pressure estimations. Non-invasive pressure-volume loop analysis enhances the understanding of the effects of TAVR on the change in global stroke work, ventricular energetics and ventriculo-arterial coupling and may aid clinicians in the assessment of patients with AS.</p>
</sec>
</body>
<back>
<sec id="s7" sec-type="data-availability"><title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s8" sec-type="ethics-statement"><title>Ethics statement</title>
<p>The studies involving humans were approved by The Norwegian Regional Committee for Medical Research Ethics. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.</p>
</sec>
<sec id="s9" sec-type="author-contributions"><title>Author contributions</title>
<p>DR: Conceptualization, Data curation, Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft, Software, Investigation, Methodology, Formal analysis. ER: Writing &#x2013; review &#x0026; editing, Software. OS: Writing &#x2013; review &#x0026; editing. RM: Investigation, Writing &#x2013; review &#x0026; editing. CE: Writing &#x2013; review &#x0026; editing, Investigation. J-PK: Writing &#x2013; review &#x0026; editing. LG: Writing &#x2013; review &#x0026; editing. KB: Writing &#x2013; review &#x0026; editing, Supervision. KR: Writing &#x2013; review &#x0026; editing, Supervision.</p>
</sec>
<sec id="s11" sec-type="COI-statement"><title>Conflict of interest</title>
<p>KR is co-inventor of the &#x201C;Method for myocardial work analysis&#x201D;, currently licenced by General Electrics. OS is also co-inventor of the method for myocardial work analysis and has patent on &#x201C;Estimation of blood pressure in the heart&#x201D;. He has received one lecture fee from GE Healthcare. DR has engaged in direct discussions with representatives from GE Healthcare concerning the potential integration of our proposed non-invasive method for pressure-volume analysis into their clinically assessable software, EchoPAC. As of this date, there is no formal agreement in place regarding this collaboration.</p>
<p>The remaining author(s) declared that the research this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s12" sec-type="ai-statement"><title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. During the preparation of this manuscript, the first author utilized ChatGPT, licensed to the University of Oslo, to correct grammatical errors and enhance the clarity of specific sentences. After employing this tool, the author reviewed and edited the content as necessary and accepts full responsibility for the publication&#x0027;s content.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s14" sec-type="disclaimer"><title>Publisher&#x0027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s13" sec-type="supplementary-material"><title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcvm.2025.1740710/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcvm.2025.1740710/full&#x0023;supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image1.tif" id="SM1" mimetype="image/tiff"><label>Supplementary Figure 1</label>
<caption><p>Study Cohort.</p></caption></supplementary-material>
<supplementary-material xlink:href="Image2.tif" id="SM2" mimetype="image/tiff"><label>Supplementary Figure 2</label>
<caption><p><bold>Inter- and intraobserver variability.</bold> A. Scatter plot comparing estimated Stroke Work (mmHg&#x002A;mL) measured by examiners A (A1) and B (B1), with the linear regression equation, intraclass correlation coefficient (ICC), and Pearson&#x0027;s correlation coefficient (r). B. Scatter plot comparing estimated Stroke Work (mmHg&#x002A;mL) measured by examiner A at two time points (A1 and A2), with the linear regression equation, ICC, and Pearson&#x0027;s r. C. Bland-Altman plot comparing estimated Stroke Work (mmHg&#x002A;mL) measured by examiners A (A1) and B (B1), showing the mean bias (mean difference) and the 95&#x0025; limits of agreement. D. Bland-Altman plot comparing estimated Stroke Work (mmHg&#x002A;mL) measured by examiner A at two time points (A1 and A2), showing the mean bias and the 95&#x0025; limits of agreement.</p></caption></supplementary-material>
</sec>
<ref-list><title>References</title>
<ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasayama</surname> <given-names>S</given-names></name> <name><surname>Ross</surname> <given-names>J</given-names></name> <name><surname>Franklin</surname> <given-names>D</given-names></name> <name><surname>Bloor</surname> <given-names>CM</given-names></name> <name><surname>Bishop</surname> <given-names>S</given-names></name> <name><surname>Dilley</surname> <given-names>RB</given-names></name></person-group>. <article-title>Adaptations of the left ventricle to chronic pressure overload</article-title>. <source>Circ Res</source>. (<year>1976</year>) <volume>38</volume>(<issue>3</issue>):<fpage>172</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1161/01.RES.38.3.172</pub-id></mixed-citation></ref>
<ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dweck</surname> <given-names>MR</given-names></name> <name><surname>Joshi</surname> <given-names>S</given-names></name> <name><surname>Murigu</surname> <given-names>T</given-names></name> <name><surname>Gulati</surname> <given-names>A</given-names></name> <name><surname>Alpendurada</surname> <given-names>F</given-names></name> <name><surname>Jabbour</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance</article-title>. <source>J Cardiovasc Magn Reson</source>. (<year>2012</year>) <volume>14</volume>(<issue>1</issue>):<fpage>50</fpage>. <pub-id pub-id-type="doi">10.1186/1532-429X-14-50</pub-id><pub-id pub-id-type="pmid">22839417</pub-id></mixed-citation></ref>
<ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname> <given-names>NHS</given-names></name> <name><surname>S&#x00F6;rensen</surname> <given-names>J</given-names></name> <name><surname>Harms</surname> <given-names>HJ</given-names></name> <name><surname>Kim</surname> <given-names>WY</given-names></name> <name><surname>Nielsen</surname> <given-names>R</given-names></name> <name><surname>Tolbod</surname> <given-names>LP</given-names></name><etal/></person-group> <article-title>Myocardial oxygen consumption and efficiency in aortic valve stenosis patients with and without heart failure</article-title>. <source>J Am Heart Assoc</source>. (<year>2017</year>) <volume>6</volume>(<issue>2</issue>):<fpage>e004810</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.116.004810</pub-id><pub-id pub-id-type="pmid">28167498</pub-id></mixed-citation></ref>
<ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urheim</surname> <given-names>S</given-names></name> <name><surname>Edvardsen</surname> <given-names>T</given-names></name> <name><surname>Torp</surname> <given-names>H</given-names></name> <name><surname>Angelsen</surname> <given-names>B</given-names></name> <name><surname>Smiseth</surname> <given-names>OA</given-names></name></person-group>. <article-title>Myocardial strain by Doppler echocardiography. Validation of a new method to quantify regional myocardial function</article-title>. <source>Circulation</source>. (<year>2000</year>) <volume>102</volume>(<issue>10</issue>):<fpage>1158</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.102.10.1158</pub-id><pub-id pub-id-type="pmid">10973846</pub-id></mixed-citation></ref>
<ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruppert</surname> <given-names>M</given-names></name> <name><surname>Lakatos</surname> <given-names>BK</given-names></name> <name><surname>Braun</surname> <given-names>S</given-names></name> <name><surname>Tokodi</surname> <given-names>M</given-names></name> <name><surname>Karime</surname> <given-names>C</given-names></name> <name><surname>Ol&#x00E1;h</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Longitudinal strain reflects ventriculoarterial coupling rather than mere contractility in rat models of hemodynamic overload-induced heart failure</article-title>. <source>J Am Soc Echocardiogr</source>. (<year>2020</year>) <volume>33</volume>(<issue>10</issue>):<fpage>1264</fpage>&#x2013;<lpage>75.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2020.05.017</pub-id><pub-id pub-id-type="pmid">32778499</pub-id></mixed-citation></ref>
<ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakatos</surname> <given-names>BK</given-names></name> <name><surname>Ruppert</surname> <given-names>M</given-names></name> <name><surname>Tokodi</surname> <given-names>M</given-names></name> <name><surname>Ol&#x00E1;h</surname> <given-names>A</given-names></name> <name><surname>Braun</surname> <given-names>S</given-names></name> <name><surname>Karime</surname> <given-names>C</given-names></name><etal/></person-group> <article-title>Myocardial work index: a marker of left ventricular contractility in pressure- or volume overload-induced heart failure</article-title>. <source>ESC Heart Fail</source>. (<year>2021</year>) <volume>8</volume>(<issue>3</issue>):<fpage>2220</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/ehf2.13314</pub-id><pub-id pub-id-type="pmid">33754487</pub-id></mixed-citation></ref>
<ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribic</surname> <given-names>D</given-names></name> <name><surname>Remme</surname> <given-names>EW</given-names></name> <name><surname>Smiseth</surname> <given-names>OA</given-names></name> <name><surname>Massey</surname> <given-names>RJ</given-names></name> <name><surname>Eek</surname> <given-names>CH</given-names></name> <name><surname>Kvitting</surname> <given-names>JP</given-names></name><etal/></person-group> <article-title>Non-invasive myocardial work in aortic stenosis: validation and improvement in left ventricular pressure estimation</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. (<year>2024</year>) <volume>25</volume>(<issue>2</issue>):<fpage>201</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jead227</pub-id><pub-id pub-id-type="pmid">37672652</pub-id></mixed-citation></ref>
<ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>K</given-names></name> <name><surname>Eriksen</surname> <given-names>M</given-names></name> <name><surname>Aaberge</surname> <given-names>L</given-names></name> <name><surname>Wilhelmsen</surname> <given-names>N</given-names></name> <name><surname>Skulstad</surname> <given-names>H</given-names></name> <name><surname>Remme</surname> <given-names>EW</given-names></name><etal/></person-group> <article-title>A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work</article-title>. <source>Eur Heart J</source>. (<year>2012</year>) <volume>33</volume>(<issue>6</issue>):<fpage>724</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehs016</pub-id><pub-id pub-id-type="pmid">22315346</pub-id></mixed-citation></ref>
<ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastos</surname> <given-names>MB</given-names></name> <name><surname>Burkhoff</surname> <given-names>D</given-names></name> <name><surname>Maly</surname> <given-names>J</given-names></name> <name><surname>Daemen</surname> <given-names>J</given-names></name> <name><surname>den Uil</surname> <given-names>CA</given-names></name> <name><surname>Ameloot</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Invasive invasive left ventricle pressure-volume analysis: overview and practical clinical implications</article-title>. <source>Eur Heart J</source>. (<year>2020</year>) <volume>41</volume>(<issue>12</issue>):<fpage>1286</fpage>&#x2013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehz552</pub-id><pub-id pub-id-type="pmid">31435675</pub-id></mixed-citation></ref>
<ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suga</surname> <given-names>H</given-names></name></person-group>. <article-title>Total mechanical energy of a ventricle model and cardiac oxygen consumption</article-title>. <source>Am J Physiol</source>. (<year>1979</year>) <volume>236</volume>(<issue>3</issue>):<fpage>H498</fpage>&#x2013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.1979.236.3.H498</pub-id><pub-id pub-id-type="pmid">426086</pub-id></mixed-citation></ref>
<ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotzmann</surname> <given-names>M</given-names></name> <name><surname>Hauptmann</surname> <given-names>S</given-names></name> <name><surname>Hogeweg</surname> <given-names>M</given-names></name> <name><surname>Choudhury</surname> <given-names>DS</given-names></name> <name><surname>Schiedat</surname> <given-names>F</given-names></name> <name><surname>Dietrich</surname> <given-names>JW</given-names></name><etal/></person-group> <article-title>Hemodynamics of paradoxical severe aortic stenosis: insight from a pressure&#x2013;volume loop analysis</article-title>. <source>Clin Res Cardiol</source>. (<year>2019</year>) <volume>108</volume>(<issue>8</issue>):<fpage>931</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00392-019-01423-z</pub-id><pub-id pub-id-type="pmid">30737530</pub-id></mixed-citation></ref>
<ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname> <given-names>R</given-names></name> <name><surname>Bajwa</surname> <given-names>T</given-names></name> <name><surname>Roemer</surname> <given-names>S</given-names></name> <name><surname>Huisheree</surname> <given-names>H</given-names></name> <name><surname>Allaqaband</surname> <given-names>SQ</given-names></name> <name><surname>Kroboth</surname> <given-names>S</given-names></name><etal/></person-group> <article-title>Myocardial work assessment in severe aortic stenosis undergoing transcatheter aortic valve replacement</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. (<year>2021</year>) <volume>22</volume>(<issue>6</issue>):<fpage>715</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jeaa257</pub-id><pub-id pub-id-type="pmid">33106854</pub-id></mixed-citation></ref>
<ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname> <given-names>K</given-names></name> <name><surname>Eriksen</surname> <given-names>M</given-names></name> <name><surname>Aaberge</surname> <given-names>L</given-names></name> <name><surname>Wilhelmsen</surname> <given-names>N</given-names></name> <name><surname>Skulstad</surname> <given-names>H</given-names></name> <name><surname>Gjesdal</surname> <given-names>O</given-names></name><etal/></person-group> <article-title>Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. (<year>2013</year>) <volume>305</volume>(<issue>7</issue>):<fpage>H996</fpage>&#x2013;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00191.2013</pub-id><pub-id pub-id-type="pmid">23893165</pub-id></mixed-citation></ref>
<ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammersboen</surname> <given-names>L-ER</given-names></name> <name><surname>Boe</surname> <given-names>E</given-names></name> <name><surname>Duchenne</surname> <given-names>J</given-names></name> <name><surname>Aalen</surname> <given-names>JM</given-names></name> <name><surname>Odland</surname> <given-names>HH</given-names></name> <name><surname>Villegas-Martinez</surname> <given-names>M</given-names></name><etal/></person-group> <article-title>Non-Invasive pressure-volume analysis by three-dimensional echocardiography: a novel powerful method for evaluating left ventricular function</article-title>. <source>J Am Soc Echocardiogr</source>. (<year>2025</year>) <volume>38</volume>(<issue>10</issue>):<fpage>946</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.echo.2025.05.008</pub-id><pub-id pub-id-type="pmid">40412539</pub-id></mixed-citation></ref>
<ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuneman</surname> <given-names>JH</given-names></name> <name><surname>Butcher</surname> <given-names>SC</given-names></name> <name><surname>Singh</surname> <given-names>GK</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Hirasawa</surname> <given-names>K</given-names></name> <name><surname>van der Kley</surname> <given-names>F</given-names></name><etal/></person-group> <article-title>Prognostic implications of change in left ventricular ejection fraction after transcatheter aortic valve implantation</article-title>. <source>Am J Cardiol</source>. (<year>2022</year>) <volume>177</volume>:<fpage>90</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2022.04.060</pub-id><pub-id pub-id-type="pmid">35691708</pub-id></mixed-citation></ref>
<ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehdipoor</surname> <given-names>G</given-names></name> <name><surname>Chen</surname> <given-names>S</given-names></name> <name><surname>Chatterjee</surname> <given-names>S</given-names></name> <name><surname>Torkian</surname> <given-names>P</given-names></name> <name><surname>Ben-Yehuda</surname> <given-names>O</given-names></name> <name><surname>Leon</surname> <given-names>MB</given-names></name><etal/></person-group> <article-title>Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies</article-title>. <source>J Cardiovasc Magn Reson</source>. (<year>2020</year>) <volume>22</volume>(<issue>1</issue>):<fpage>41</fpage>. <pub-id pub-id-type="doi">10.1186/s12968-020-00629-9</pub-id><pub-id pub-id-type="pmid">32475350</pub-id></mixed-citation></ref>
<ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname> <given-names>A</given-names></name> <name><surname>Hassager</surname> <given-names>C</given-names></name> <name><surname>Thyregod</surname> <given-names>HGH</given-names></name> <name><surname>S&#x00F8;ndergaard</surname> <given-names>L</given-names></name> <name><surname>Olsen</surname> <given-names>PS</given-names></name> <name><surname>Steinbr&#x00FC;chel</surname> <given-names>D</given-names></name><etal/></person-group> <article-title>Differences in left ventricular remodelling in patients with aortic stenosis treated with transcatheter aortic valve replacement with corevalve prostheses compared to surgery with porcine or bovine biological prostheses</article-title>. <source>Eur Heart J Cardiovasc Imaging</source>. (<year>2018</year>) <volume>19</volume>(<issue>1</issue>):<fpage>39</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1093/ehjci/jew321</pub-id><pub-id pub-id-type="pmid">28158582</pub-id></mixed-citation></ref>
<ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname> <given-names>K</given-names></name> <name><surname>Kumar</surname> <given-names>A</given-names></name> <name><surname>Jones</surname> <given-names>BM</given-names></name> <name><surname>Mick</surname> <given-names>SL</given-names></name> <name><surname>Krishnaswamy</surname> <given-names>A</given-names></name> <name><surname>Grimm</surname> <given-names>RA</given-names></name><etal/></person-group> <article-title>Reversibility of cardiac function predicts outcome after transcatheter aortic valve replacement in patients with severe aortic stenosis</article-title>. <source>J Am Heart Assoc</source>. (<year>2017</year>) <volume>6</volume>(<issue>7</issue>):<fpage>e005798</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.117.005798</pub-id><pub-id pub-id-type="pmid">28698259</pub-id></mixed-citation></ref>
<ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monge Garc&#x00ED;a</surname> <given-names>MI</given-names></name> <name><surname>Santos</surname> <given-names>A</given-names></name></person-group>. <article-title>Understanding ventriculo-arterial coupling</article-title>. <source>Ann Transl Med</source>. (<year>2020</year>) <volume>8</volume>(<issue>12</issue>):<fpage>795</fpage>. <pub-id pub-id-type="doi">10.21037/atm.2020.04.10</pub-id></mixed-citation></ref>
<ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorosz</surname> <given-names>JL</given-names></name> <name><surname>Lezotte</surname> <given-names>DC</given-names></name> <name><surname>Weitzenkamp</surname> <given-names>DA</given-names></name> <name><surname>Allen</surname> <given-names>LA</given-names></name> <name><surname>Salcedo</surname> <given-names>EE</given-names></name></person-group>. <article-title>Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis</article-title>. <source>J Am Coll Cardiol</source>. (<year>2012</year>) <volume>59</volume>(<issue>20</issue>):<fpage>1799</fpage>&#x2013;<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2012.01.037</pub-id><pub-id pub-id-type="pmid">22575319</pub-id></mixed-citation></ref></ref-list>
<fn-group>
<fn id="n1" fn-type="custom" custom-type="edited-by"><p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1100198/overview">Attila Kovacs</ext-link>, Semmelweis University, Hungary</p></fn>
<fn id="n2" fn-type="custom" custom-type="reviewed-by"><p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/848668/overview">Choon-Sik Jhun</ext-link>, The Pennsylvania State University, United States</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1368619/overview">Balint Karoly Lakatos</ext-link>, Semmelweis University, Hungary</p></fn>
<fn fn-type="abbr" id="abbrev1"><p><bold>Abbreviations</bold> AS, aortic stenosis; GLS, global longitudinal strain; LV, left ventricular; LVP, left ventricular pressure; MWI, myocardial work index; TAVR, transcatheter aortic valve replacement; 2D, two-dimensional; 3D, three-dimensional.</p></fn>
</fn-group>
</back>
</article>